Arcus Biosciences reports 26.7-month median survival and 59% response rate in Phase 2 cancer study with domvanalimab ...
Allie Martin will never forget when she discovered distance running. “I ran my first race when I was around 5 or 6,” she said ...
Kedrion Biopharma announced today that it has received FDA approval for QIVIGY immune globulin intravenous (human)-kthm 10% ...
The FDA has approved Kedrion Biopharma’s Qivigy, a 10% IV immunoglobulin therapy, for treating adults who have primary ...
FDA approves Merck's Keytruda Qlex injection for adults with solid tumors. Merck expects it to be available in the U.S. in September.
Qivigy (immune globulin intravenous, human-kthm) is a ready-to-use, sterile, non-pyrogenic liquid solution of human immune globulin for IV administration.
Dr. Singhi speaks with us about the importance of biomarker testing and what you need to know to get the best lung cancer ...
Splenic Rupture Post-Caesarean Section. Open Journal of Nursing, 15, 848-862. doi: 10.4236/ojn.2025.1510061 . The spleen is a ...
Shattuck Labs, Inc. ( NASDAQ: STTK) The United European Gastroenterology (UEG) Congress UEG Week 2025 October 8, 2025 10:00 AM EDT ...
Discover BioVie's latest clinical advancements in Parkinson's, long COVID, and ascites. Learn about investment potential and upcoming data readouts.
Hospitals in 2025 are looking a lot different, but not because of fancy robots or new machines. The real change is coming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback